[{"address1": "1111 Dr. Frederik-Philips Boulevard", "address2": "Suite 420", "city": "Montreal", "state": "QC", "zip": "H4M 2X6", "country": "Canada", "phone": "514-336-0444", "website": "https://www.milestonepharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which has completed phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.", "fullTimeEmployees": 33, "companyOfficers": [{"maxAge": 1, "name": "Mr. Joseph G. Oliveto M.B.A.", "age": 56, "title": "CEO, President & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 882261, "exercisedValue": 0, "unexercisedValue": 255224}, {"maxAge": 1, "name": "Mr. Amit  Hasija", "age": 51, "title": "CFO & Executive VP of Corporate Development", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 601517, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David B. Bharucha FACC, M.D., Ph.D.", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 636174, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philippe  Douville M.B.A., Ph.D.", "age": 62, "title": "Founder, Strategic Advisor & Member of Scientific Advisory Board", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeffrey  Nelson", "age": 43, "title": "Chief Operating Officer", "yearBorn": 1981, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kim  Fox", "title": "Vice President of Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Roshan  Girglani", "title": "Vice President of Marketing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeff  Moore", "title": "Vice President of Sales", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philip T. Sager FACC, FAHA, FHRS, M.D.", "age": 68, "title": "Chief Medical Advisor & Member of the Scientific Advisory Board", "yearBorn": 1956, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Guy  Rousseau", "title": "SVP of Regulatory Affairs and Quality Management", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.69, "open": 1.68, "dayLow": 1.6505, "dayHigh": 1.79, "regularMarketPreviousClose": 1.69, "regularMarketOpen": 1.68, "regularMarketDayLow": 1.6505, "regularMarketDayHigh": 1.79, "payoutRatio": 0.0, "beta": 0.917, "forwardPE": -2.0465117, "volume": 1025778, "regularMarketVolume": 1025778, "averageVolume": 2078258, "averageVolume10days": 556900, "averageDailyVolume10Day": 556900, "bid": 1.76, "ask": 1.8, "bidSize": 5, "askSize": 5, "marketCap": 94097168, "fiftyTwoWeekLow": 0.625, "fiftyTwoWeekHigh": 2.75, "fiftyDayAverage": 1.36366, "twoHundredDayAverage": 1.655025, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 116448760, "profitMargins": 0.0, "floatShares": 50946026, "sharesOutstanding": 53464300, "sharesShort": 2118339, "sharesShortPriorMonth": 2365630, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.0396, "heldPercentInsiders": 0.0471, "heldPercentInstitutions": 0.22252001, "shortRatio": 2.01, "shortPercentOfFloat": 0.0396, "impliedSharesOutstanding": 53327900, "bookValue": -0.092, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -51926000, "trailingEps": -0.77, "forwardEps": -0.86, "enterpriseToEbitda": -2.237, "52WeekChange": 0.36434114, "SandP52WeekChange": 0.10163462, "quoteType": "EQUITY", "currentPrice": 1.76, "targetHighPrice": 5.0, "targetLowPrice": 1.0, "targetMeanPrice": 3.33333, "targetMedianPrice": 4.0, "recommendationMean": 2.5, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 55958000, "totalCashPerShare": 0.843, "ebitda": -52045000, "totalDebt": 55587000, "quickRatio": 4.431, "currentRatio": 4.665, "returnOnAssets": -0.41287, "returnOnEquity": -3.07273, "freeCashflow": -19449624, "operatingCashflow": -33866000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MIST", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1557408600000, "shortName": "Milestone Pharmaceuticals Inc.", "regularMarketChange": 0.0699999, "regularMarketDayRange": "1.6505 - 1.79", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2078258, "fiftyTwoWeekLowChange": 1.135, "fiftyTwoWeekLowChangePercent": 1.816, "fiftyTwoWeekRange": "0.625 - 2.75", "fiftyTwoWeekHighChange": -0.99, "fiftyTwoWeekHighChangePercent": -0.36, "fiftyTwoWeekChangePercent": 36.434113, "earningsTimestamp": 1747220695, "earningsTimestampStart": 1754483400, "earningsTimestampEnd": 1754915400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.77, "epsForward": -0.86, "epsCurrentYear": -0.81667, "priceEpsCurrentYear": -2.1550932, "fiftyDayAverageChange": 0.39634, "fiftyDayAverageChangePercent": 0.29064432, "twoHundredDayAverageChange": 0.104974985, "twoHundredDayAverageChangePercent": 0.06342804, "marketState": "PRE", "regularMarketChangePercent": 4.14201, "regularMarketPrice": 1.76, "priceToBook": -19.130434, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.5 - Buy", "cryptoTradeable": false, "corporateActions": [], "longName": "Milestone Pharmaceuticals Inc.", "regularMarketTime": 1750708801, "exchange": "NMS", "messageBoardId": "finmb_36171059", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Milestone Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-06-24"}]